0       0

AST 2014 - Cutting Edge of Transplantation


SA04a - Did Our Drugs 'Fail Our Patients' or Did Our Trials 'Fail Our Drugs'?


Feb 15, 2014 5:30pm ‐ Feb 15, 2014 6:00pm

Description

This talk will set the discussion and outline current testing of drugs and how our approaches may have been limiting and inadequate. Did traditional trial endpoints terminate drugs that should have succeeded? Could genomics or alternative endpoints have impacted clinical trial design?

Speaker(s):

  • Randy Morris, MD, FRCP, Stanford University School of Medicine

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content